AU Patent

AU2015313875B2 — Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole

Assigned to Pfizer Inc · Expires 2018-03-15 · 8y expired

What this patent protects

The present invention relates to solid forms of 6-carboxy-2-(3,5-dichlorophenyl)- benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such …

USPTO Abstract

The present invention relates to solid forms of 6-carboxy-2-(3,5-dichlorophenyl)- benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015313875B2
Jurisdiction
AU
Classification
—
Expires
2018-03-15
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.